MAP9 Exhibits Protumor Activities and Immune Escape toward Bladder Cancer by Mediating TGF-β1 Pathway

Figure 10

MAP9 mediates immune escape in bladder cancer. (a) The correlation between MAP9 and immune cell infiltration in the TCGA-BLCA cohort. (b) The correlation between MAP9 and GZMB in the TCGA-BLCA cohort.(c) The differences of prognosis between different expressed MAP9 and cytotoxic T lymphocyte infiltration with TIDE algorithm in the GSE31684 cohort.

(a)

(b)

(c)